1. Home
  2. LRMR vs PESI Comparison

LRMR vs PESI Comparison

Compare LRMR & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • PESI
  • Stock Information
  • Founded
  • LRMR N/A
  • PESI 1990
  • Country
  • LRMR United States
  • PESI United States
  • Employees
  • LRMR N/A
  • PESI N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • PESI Environmental Services
  • Sector
  • LRMR Health Care
  • PESI Industrials
  • Exchange
  • LRMR Nasdaq
  • PESI Nasdaq
  • Market Cap
  • LRMR 183.8M
  • PESI 191.9M
  • IPO Year
  • LRMR N/A
  • PESI 1992
  • Fundamental
  • Price
  • LRMR $2.04
  • PESI $7.04
  • Analyst Decision
  • LRMR Strong Buy
  • PESI Strong Buy
  • Analyst Count
  • LRMR 10
  • PESI 1
  • Target Price
  • LRMR $19.60
  • PESI $18.00
  • AVG Volume (30 Days)
  • LRMR 911.3K
  • PESI 185.0K
  • Earning Date
  • LRMR 03-24-2025
  • PESI 03-13-2025
  • Dividend Yield
  • LRMR N/A
  • PESI N/A
  • EPS Growth
  • LRMR N/A
  • PESI N/A
  • EPS
  • LRMR N/A
  • PESI N/A
  • Revenue
  • LRMR N/A
  • PESI $59,117,000.00
  • Revenue This Year
  • LRMR N/A
  • PESI $38.20
  • Revenue Next Year
  • LRMR N/A
  • PESI $98.88
  • P/E Ratio
  • LRMR N/A
  • PESI N/A
  • Revenue Growth
  • LRMR N/A
  • PESI N/A
  • 52 Week Low
  • LRMR $2.07
  • PESI $6.91
  • 52 Week High
  • LRMR $11.20
  • PESI $16.25
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 31.08
  • PESI 40.13
  • Support Level
  • LRMR $2.19
  • PESI $6.91
  • Resistance Level
  • LRMR $2.44
  • PESI $8.23
  • Average True Range (ATR)
  • LRMR 0.18
  • PESI 0.47
  • MACD
  • LRMR -0.01
  • PESI 0.09
  • Stochastic Oscillator
  • LRMR 5.19
  • PESI 17.80

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: Treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

Share on Social Networks: